7Baggers
 Clearmind files patent for MEAI and PEA combination to treat depression By Investing.com  Investing.com South Africa Mon, 17 Nov 2025 13:15:39 GMT
 clearmind medicine receives approval for aud clinical trial site by investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:05:07 GMT
 Clearmind Medicine receives approval for AUD clinical trial site  Investing.com Thu, 13 Nov 2025 14:11:14 GMT
 12 Health Care Stocks Moving In Wednesday's Intraday Session  Benzinga Wed, 12 Nov 2025 17:05:53 GMT
 12 Health Care Stocks Moving In Tuesday's After-Market Session  Benzinga Tue, 11 Nov 2025 21:07:32 GMT
 Clearmind completes first patient cohort in AUD treatment trial By Investing.com  Investing.com Nigeria Tue, 11 Nov 2025 06:55:14 GMT
 Clearmind completes first patient cohort in AUD treatment trial  Investing.com Mon, 10 Nov 2025 13:25:59 GMT
 Why Is Clearmind Stock Down Today?  Sahm Fri, 07 Nov 2025 08:00:00 GMT
 clearmind medicine files patent application in south korea  TipRanks Wed, 05 Nov 2025 14:44:35 GMT
 published on: 2025-11-05 00:15:14  newser.com Wed, 05 Nov 2025 06:15:14 GMT
 published on: 2025-11-03 01:01:42  newser.com Mon, 03 Nov 2025 07:01:42 GMT

Clearmind Medicine Inc.
(NASDAQ:CMND) 

CMND stock logo

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental heal...

Founded: 2017
IPO Price: $6.50 (Nov 15, 2022)
CEO: Adi Zuloff-Shani  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends